Abstract
Restless legs syndrome (RLS) and periodic limb movements during sleep (PLMS) are two common sleep disorders, affecting approximately 5–10% of the general population. The association between RLS/PLMS and cardiovascular disease and cardiovascular risk factors has been examined extensively during the past decade. However, most of these studies are cross-sectional and thus the temporary relationship between RLS and CVD cannot be determined. There are only few well-designed prospective studies on this topic available to date, generating inconsistent results. Further large-scale prospective studies, using standardized approach for RLS/PLMS assessment, are warranted.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Broman JE, Mallon L, Hetta J. Restless legs syndrome and its relationship with insomnia symptoms and daytime distress: epidemiological survey in Sweden. Psychiatry Clin Neurosci. 2008;62:472–5.
Earley CJ, Silber MH. Restless legs syndrome: understanding its consequences and the need for better treatment. Sleep Med. 2010;11:807–15.
Yang C, Winkelman JW. Clinical and polysomnographic characteristics of high frequency leg movements. J Clin Sleep Med. 2010;6:431–8.
Allen RP, Walters AS, Montplaisir J, Hening W, Myers A, et al. Restless legs syndrome prevalence and impact: REST general population study. Arch Intern Med. 2005;165:1286–92.
Hornyak M. Depressive disorders in restless legs syndrome: epidemiology, pathophysiology and management. CNS Drugs. 2010;24:89–98.
Ohayon MM, O’Hara R, Vitiello MV. Epidemiology of restless legs syndrome: a synthesis of the literature. Sleep Med Rev. 2012;16:283–95.
Loewen A, Siemens A, Hanly P. Sleep disruption in patients with sleep apnea and end-stage renal disease. J Clin Sleep Med. 2009;5:324–9.
Merlino G, Fratticci L, Valente M, Del Giudice A, Noacco C, et al. Association of restless legs syndrome in type 2 diabetes: a case-control study. Sleep. 2007;30:866–71.
Araujo SM, de Bruin VM, Nepomuceno LA, Maximo ML, Daher Ede F, et al. Restless legs syndrome in end-stage renal disease: clinical characteristics and associated comorbidities. Sleep Med. 2010;11:785–90.
Gao X, Schwarzschild MA, Wang H, Ascherio A. Obesity and restless legs syndrome in men and women. Neurology. 2009;72:1255–61.
Li Y, Walters AS, Chiuve SE, Rimm EB, Winkelman JW, et al. Prospective study of restless legs syndrome and coronary heart disease among women. Circulation. 2012;126:1689–94.
Li Y, Mirzaei F, O’Reilly EJ, Winkelman JW, Malhotra A, et al. Prospective study of restless legs syndrome and risk of depression in women. Am J Epidemiol. 2012;176:279–88.
Phillips B, Young T, Finn L, Asher K, Hening WA, et al. Epidemiology of restless legs symptoms in adults. Arch Intern Med. 2000;160:2137–41.
Ohayon MM, Roth T. Prevalence of restless legs syndrome and periodic limb movement disorder in the general population. J Psychosom Res. 2002;53:547–54.
Kim J, Choi C, Shin K, Yi H, Park M, et al. Prevalence of restless legs syndrome and associated factors in the Korean adult population: the Korean health and genome study. Psychiatry Clin Neurosci. 2005;59:350–3.
Moller C, Wetter TC, Koster J, Stiasny-Kolster K. Differential diagnosis of unpleasant sensations in the legs: prevalence of restless legs syndrome in a primary care population. Sleep Med. 2010;11:161–6.
Winter AC, Berger K, Glynn RJ, Buring JE, Gaziano JM, et al. Vascular risk factors, cardiovascular disease, and restless legs syndrome in men. Am J Med. 2013; 126:228–35, e221–2.
Winter AC, Schurks M, Glynn RJ, Buring JE, Gaziano JM, et al. Vascular risk factors, cardiovascular disease, and restless legs syndrome in women. Am J Med. 2013;126:220–27, e221–2.
Sevim S, Dogu O, Camdeviren H, Bugdayci R, Sasmaz T, et al. Unexpectedly low prevalence and unusual characteristics of RLS in Mersin, Turkey. Neurology. 2003;61:1562–9.
Berger K, Luedemann J, Trenkwalder C, John U, Kessler C. Sex and the risk of restless legs syndrome in the general population. Arch Intern Med. 2004;164:196–202.
De Vito K, Li Y, Batool-Anwar S, Ning Y, Han J, et al. Prospective study of obesity, hypertension, high cholesterol and risk of restless legs syndrome. Mov Disord. 2014;29(8):1044–52.
Szentkiralyi A, Volzke H, Hoffmann W, Happe S, Berger K. A time sequence analysis of the relationship between cardiovascular risk factors, vascular diseases and restless legs syndrome in the general population. J Sleep Res. 2013;22:434–42.
Ulfberg J, Nyström B, Carter N, Edling C. Prevalence of restless legs syndrome among men aged 18 to 64 years: an association with somatic disease and neuropsychiatric symptoms. Mov Disord. 2001;16:1159–63.
Phillips B, Hening W, Britz P, Mannino D. Prevalence and correlates of restless legs syndrome*. Chest. 2006;129:76–80.
Budhiraja P, Budhiraja R, Goodwin JL, Allen RP, Newman AB, et al. Incidence of restless legs syndrome and its correlates. J Clin Sleep Med JCSM Official Publ Am Acad Sleep Med. 2012;8:119–24.
Szentkiralyi A, Volzke H, Hoffmann W, Baune BT, Berger K. The relationship between depressive symptoms and restless legs syndrome in two prospective cohort studies. Psychosom Med. 2013;75:359–65.
Schlesinger I, Erikh I, Avizohar O, Sprecher E, Yarnitsky D. Cardiovascular risk factors in restless legs syndrome. Mov Disord. 2009;24:1587–92.
Winkelman JW, Finn L, Young T. Prevalence and correlates of restless legs syndrome symptoms in the Wisconsin Sleep Cohort. Sleep Med. 2006;7:545–52.
Winkelman JW, Shahar E, Sharief I, Gottlieb DJ. Association of restless legs syndrome and cardiovascular disease in the sleep heart health study. Neurology. 2008;70:35–42.
Espinar-Sierra J, Vela-Bueno A, Luque-Otero M. Periodic leg movements in sleep in essential hypertension. Psychiatry Clin Neurosci. 1997;51:103–7.
Elwood P, Hack M, Pickering J, Hughes J, Gallacher J. Sleep disturbance, stroke, and heart disease events: evidence from the Caerphilly cohort. J Epidemiol Commun Health. 2006;60:69–73.
Li Y, Walters AS, Chiuve SE, Rimm EB, Winkelman JW, et al. Prospective study of restless legs syndrome and coronary heart disease among women. Circulation. 2012;126:1689–94.
Winter AC, Schurks M, Glynn RJ, Buring JE, Gaziano JM, et al. Restless legs syndrome and risk of incident cardiovascular disease in women and men: prospective cohort study. BMJ Open. 2012;2:e000866.
Jose PA, Eisner GM, Felder RA. Role of dopamine in the pathogenesis of hypertension. Clin Exp Pharmacol Physiol Suppl. 1999;26:S10–3.
Ali NJ, Davies RJ, Fleetham JA, Stradling JR. Periodic movements of the legs during sleep associated with rises in systemic blood pressure. Sleep. 1991;14:163–5.
Gangwisch JE, Heymsfield SB, Boden-Albala B, Buijs RM, Kreier F, et al. Short sleep duration as a risk factor for hypertension: analyses of the first national health and nutrition examination survey. Hypertension. 2006;47:833–9.
Pennestri MH, Montplaisir J, Colombo R, Lavigne G, Lanfranchi PA. Nocturnal blood pressure changes in patients with restless legs syndrome. Neurology. 2007;68:1213–8.
Siddiqui F, Strus J, Ming X, Lee IA, Chokroverty S, et al. Rise of blood pressure with periodic limb movements in sleep and wakefulness. Clin Neurophysiol. 2007;118:1923–30.
Walters AS, Rye DB. Review of the relationship of restless legs syndrome and periodic limb movements in sleep to hypertension, heart disease, and stroke. Sleep. 2009;32:589–97.
Winkelman JW. The evoked heart rate response to periodic leg movements of sleep. Sleep. 1999;22:575–80.
Davies RJ, Belt PJ, Roberts SJ, Ali NJ, Stradling JR. Arterial blood pressure responses to graded transient arousal from sleep in normal humans. J Appl Physiol. 1993;74:1123–30.
Ekstedt M, Akerstedt T, Soderstrom M. Microarousals during sleep are associated with increased levels of lipids, cortisol, and blood pressure. Psychosom Med. 2004;66:925–31.
Javaheri S. Sleep disorders in systolic heart failure: a prospective study of 100 male patients. The final report. Int J Cardiol. 2006;106:21–8.
Skomro R, Silva R, Alves R, Figueiredo A, Lorenzi-Filho G. The prevalence and significance of periodic leg movements during sleep in patients with congestive heart failure. Sleep Breath. 2009;13:43–7.
Kimmel PL, Miller G, Mendelson WB. Sleep apnea syndrome in chronic renal disease. Am J Med. 1989;86:308–14.
Pressman MR, Benz RL, Schleifer CR, Peterson DD. Sleep disordered breathing in ESRD: acute beneficial effects of treatment with nasal continuous positive airway pressure. Kidney Int. 1993;43:1134–9.
Lindner A, Fornadi K, Lazar AS, Czira ME, Dunai A, et al. Periodic limb movements in sleep are associated with stroke and cardiovascular risk factors in patients with renal failure. J Sleep Res. 2012;21:297–307.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer Science+Business Media LLC
About this chapter
Cite this chapter
Gao, X., Koo, B. (2017). Epidemiologic Evidence in Cardiovascular Disease. In: Manconi, M., García-Borreguero, D. (eds) Restless Legs Syndrome/Willis Ekbom Disease. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-6777-3_6
Download citation
DOI: https://doi.org/10.1007/978-1-4939-6777-3_6
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4939-6775-9
Online ISBN: 978-1-4939-6777-3
eBook Packages: MedicineMedicine (R0)